The Pipeline
The Pipeline
Atani is growing its pipeline to include a broad range of cancer and supportive care drugs in all stages of development. Our goal is to select additional advanced products in the mid-term. We are currently reviewing, under CDA, a number of opportunities.
We are constantly looking for product opportunities for the Japanese market. As a small company we can offer to our partners rapid decision making, high prioritization of products, and effective licensing discussions. Should you consider Atani as partner for your valuable products we shall be pleased to discuss with you. Please contact us at info@atanipharma.com.
